Leading the way in medical advancement and treatment of ME/CFS and Fibromyalgia

Your dollar could fund the next major medical breakthrough and change the lives of millions.

Bateman-4web[1]

Lucinda Bateman, MD

Founder and Chief Medical Officer of Bateman Horne Center

Dr. Lucinda Bateman’s experience with ME/CFS and Fibromyalgia began when her sister became diagnosed. Now with 25 years of clinical and research experience, Dr. Bateman is one of the few nationally recognized clinical experts on ME/CFS, and was recently tapped by the National Academy of Medicine (formerly the Institute of Medicine [IOM]) to help establish the first evidence-based clinical diagnostic criteria for the disease. As the founder and chief medical officer of Bateman Horne Center of Excellence, Dr. Bateman is dedicated to furthering research and treatments that improve the lives of those with ME/CFS and Fibromyalgia.

Suzanne1a

Suzanne D. Vernon, PhD

Suzanne D. Vernon, PhD has joined Dr. Bateman in partnership with the Bateman Horne Center to lead a new research initiative.

Suzanne D. Vernon, PhD, is the nation’s leading researcher in ME/CFS, having raised millions of dollars for research studies that have resulted in more than 85 research papers and several international presentations to promote research and collaboration. Vernon earned her PhD in virology at the University of Wisconsin, Madison and was awarded a National Science Foundation post-doctoral fellowship at the U.S. Centers for Disease Control and Prevention (CDC). Vernon was appointed a team leader Research Microbiologist and led the ME/CFS laboratory program for 10 years. In 2007, Vernon became the first scientific director for the non-profit patient advocacy organization Solve ME/CFS Initiative.  

Integrate Medical Research

We may also offer you opportunities to participate in cutting-edge research and encourage you to join our social, education and support group events as they are a cornerstone practice in achieving wellness.

Specialty Clinical Care

We offer the highest level of specialty, patient-centered care backed by the latest medical science to help breakthrough any past road blocks or misinformation.

The Bateman Horne Center of Excellence is leading the way in the medical advancement and treatment of and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)and Fibromyalgia. About 6 million people in the US are affected by ME/CFS and Fibromyalgia—more than those with MS, lupus or many forms of cancer—yet only $15 million in combined federal dollars across all agencies is dedicated to researching these diseases. The result is a wide research and medical literature gap that has left no standard diagnostic tests and has fueled misunderstanding and disinformation among the medical community. Widespread lack of medical knowledge means that only a fraction of sufferers are diagnosed in Utah and the US, and their diseases are exacerbated with few viable treatment options. Many more sufferers remain undiagnosed, misdiagnosed and mistreated for other diseases including mental illness. Bateman Horne Center is filling these gaps through much needed integrated scientific research, clinical care, medical and lay education and advocacy.

"I hope that my commitment to contributing to progress in the CFS research field as evidenced by my “leap of faith” will give people a reason to make a leap of faith with me as well. " Suzanne Vernon, PhD

"Future projects revolve around finding reliable diagnostic tests for myalgic encephalomyelitis, chronic fatigue syndrome, and fibromyalgia that will return these conditions to mainstream medicine and science. It is within our grasp to understand the causes of these conditions, to develop tests that demonstrate the presence and severity of illness, and to develop effective treatments. "
Lucinda Bateman, MD

"For me the dots are data, and for years the challenge has been getting the data! Now technology and direct-to-consumer testing have empowered each of us — healthy and sick — to be the keeper of our own data. It is then our decision what to do with these data, who we want to share it with, whether we want to bring it together with others to reveal patterns, to reveal what’s important for recovery, to reveal causes of our maladies." Suzanne Vernon, PhD

Sign up for our Newsletter